Avail Scientific Inc., formerly Mobile Lads Corp., is a clinical-stage biopharmaceutical company. The Company is engaged in developing and testing nano-technology in conjunction with its psychedelic therapeutics. It is focused on facilitating a medical and social re-evaluation of the pharmacological therapies for addiction using organic psilocybin and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT). These substances can be used as both treatment for addiction and as preventative therapy addressing health challenges underlying substance abuse. Its program includes multi-tiered research programs and implementation of psychedelic therapy in Canada. Its psychedelic-based projects include development of psychedelic analogs for medical use, novel methods of medication absorption, and derived research. It has developed a scientific methodology that utilizes functional magnetic resonance imaging (fMRI) technology, artificial intelligence, and a licensed research facility.